Antonio
Monge Vega
Investigador hasta 2013
Instituto Mexicano del Seguro Social
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Instituto Mexicano del Seguro Social (4)
2021
-
Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors
Acta Pharmaceutica, Vol. 71, Núm. 3, pp. 485-495
2020
-
In vitro and in vivo evaluation of quinoxaline 1,4-di-n-oxide against giardia lamblia
Letters in Drug Design and Discovery, Vol. 17, Núm. 4, pp. 426-431
2018
-
Anti-mycobacterium tuberculosis activity of esters of quinoxaline 1,4-Di-N-oxide
Molecules, Vol. 23, Núm. 6
-
Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana
Parasitology Research, Vol. 117, Núm. 1, pp. 45-58